Intraductal Carcinoma — Trials

Intraductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 31
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (29)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00586326	MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ(DCIS)	completed	Phase 2	133	Hologic, Inc.INDUSTRY	1	Nov 6, 2012	clinicaltrials
NCT01100489	Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer	withdrawn	Phase 2	0	Case Comprehensive Cancer CenterOTHER	1	Dec 8, 2011	clinicaltrials